In contrast to general health and wellness apps, a new category of digital therapies is emerging to prevent, manage, and even treat medical conditions. Regardless of their clinical claims, all digital therapeutics must be evidence-based and adhere to quality, security, and usability standards. Digital therapies are being developed to address a wide range of conditions, from diabetes and asthma, to depression and opioid addiction. But where do these fit in terms of managed care access and reimbursement?


  • Benjamin Parcher
    Assistant Director, Strategic Market Access and Intelligence
  • Caroline Popper
    Popper and Company
    Co-Founder and President
** IMPORTANT: AMCP webinars are limited to the first 1000 that join the webinar. AMCP will provide a link to the recording and slides to all registrants within one week from the webinar date.

Click here for additional information and registration details.

Related Content

Evidence Matters 2022

Evidence Matters 2022

Evidence Matters is a virtual one-day summit that brings the literature review community together from different industries to learn, engage, and solve ever-pressing evidence-based research challenges.